• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia.

作者信息

Pfau Anja, Grujic Danica, Keddis Mira T, Kausz Annamaria T, Lieske John C, Knauf Felix

机构信息

Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.

Allena Pharmaceuticals, Inc., Newton, MA, USA.

出版信息

Nephrol Dial Transplant. 2021 Apr 26;36(5):945-948. doi: 10.1093/ndt/gfaa379.

DOI:10.1093/ndt/gfaa379
PMID:33416876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8075375/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a1/8075375/43e3989b6328/gfaa379f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a1/8075375/43e3989b6328/gfaa379f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35a1/8075375/43e3989b6328/gfaa379f1.jpg

相似文献

1
Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia.瑞洛沙利酶用于重症肠道高草酸尿症和高草酸血症患者的初步研究。
Nephrol Dial Transplant. 2021 Apr 26;36(5):945-948. doi: 10.1093/ndt/gfaa379.
2
Renal and intestinal handling of oxalate following oxalate loading in rats.大鼠草酸盐负荷后肾脏和肠道对草酸盐的处理
Am J Nephrol. 2003 Jan-Feb;23(1):18-26. doi: 10.1159/000066300.
3
Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.SAT-1 硫酸盐转运蛋白缺失对小鼠肠道草酸盐处理没有影响，也不会导致高草酸尿症或高草酸血症。
Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G82-G94. doi: 10.1152/ajpgi.00299.2018. Epub 2018 Nov 1.
4
Gut microbiota and oxalate homeostasis.肠道微生物群与草酸盐稳态
Ann Transl Med. 2017 Jan;5(2):36. doi: 10.21037/atm.2016.12.70.
5
Enteric hyperoxaluria: role of microbiota and antibiotics.肠源性高草酸尿症：微生物群和抗生素的作用。
Curr Opin Nephrol Hypertens. 2019 Jul;28(4):352-359. doi: 10.1097/MNH.0000000000000518.
6
Glycolate determination detects type I primary hyperoxaluria in dialysis patients.乙醇酸测定可检测透析患者的Ⅰ型原发性高草酸尿症。
Kidney Int. 1991 Jan;39(1):149-54. doi: 10.1038/ki.1991.19.
7
Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.肠道高草酸尿症、肾结石和草酸肾病：Roux-en-Y胃旁路术潜在的严重且未被重视的并发症。
Surg Obes Relat Dis. 2005 Sep-Oct;1(5):481-5. doi: 10.1016/j.soard.2005.07.002. Epub 2005 Aug 26.
8
Nephrolithiasis due to primary hyperparathyroidism and enteric hyperoxaluria: a case report.原发性甲状旁腺功能亢进和肠道高草酸尿症所致肾结石：病例报告
Urology. 1996 May;47(5):751-5. doi: 10.1016/s0090-4295(96)00025-8.
9
Case report of paediatric oxalate urolithiasis and a review of enteric hyperoxaluria.小儿草酸钙尿石症病例报告及肠源性高草酸尿症综述
J Pediatr Urol. 2010 Apr;6(2):112-6. doi: 10.1016/j.jpurol.2009.06.013. Epub 2009 Aug 6.
10
Enteric hyperoxaluria associated with external biliary drainage.与外引流相关的肠道高草酸尿症。
J Urol. 1994 Feb;151(2):396-7. doi: 10.1016/s0022-5347(17)34959-5.

引用本文的文献

1
OxDc-A0: an oral gastro-tolerant oxalate decarboxylase for treating secondary hyperoxaluria.OxDc-A0：一种用于治疗继发性高草酸尿症的口服耐胃肠草酸脱羧酶。
Urolithiasis. 2025 Mar 5;53(1):47. doi: 10.1007/s00240-025-01698-0.
2
Oxalate Homeostasis in Non-Stone-Forming Chronic Kidney Disease: A Review of Key Findings and Perspectives.非结石形成性慢性肾脏病中的草酸盐稳态：关键发现与展望综述
Biomedicines. 2023 Jun 7;11(6):1654. doi: 10.3390/biomedicines11061654.
3
Breaking the Cycle of Recurrent Calcium Stone Disease.打破复发性钙结石病的循环。

本文引用的文献

1
Pathophysiology and Treatment of Enteric Hyperoxaluria.肠源性高草酸尿症的病理生理学和治疗。
Clin J Am Soc Nephrol. 2021 Mar 8;16(3):487-495. doi: 10.2215/CJN.08000520. Epub 2020 Sep 8.
2
End Points for Clinical Trials in Primary Hyperoxaluria.原发性高草酸尿症临床试验的终点。
Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1056-1065. doi: 10.2215/CJN.13821119. Epub 2020 Mar 12.
3
The association of calcium oxalate deposition in kidney allografts with graft and patient survival.肾移植中草酸钙沉积与移植物和患者存活率的关系。
Adv Kidney Dis Health. 2023 Mar;30(2):164-176. doi: 10.1053/j.akdh.2022.12.004.
4
Oxalate homeostasis.草酸盐稳态。
Nat Rev Nephrol. 2023 Feb;19(2):123-138. doi: 10.1038/s41581-022-00643-3. Epub 2022 Nov 3.
5
Oxalate nephropathy: a review.草酸盐肾病：综述
Clin Kidney J. 2021 Aug 12;15(2):194-204. doi: 10.1093/ckj/sfab145. eCollection 2022 Feb.
Nephrol Dial Transplant. 2020 May 1;35(5):888-894. doi: 10.1093/ndt/gfy271.
4
A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.肠道（继发性）高草酸尿症患者肾移植的成功方法
Transplant Direct. 2017 Nov 8;3(12):e331. doi: 10.1097/TXD.0000000000000748. eCollection 2017 Dec.
5
Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.原发性高草酸尿症、肠道高草酸尿症和尿路结石病患者的血浆草酸盐与估算肾小球滤过率的关系
Clin Biochem. 2017 Dec;50(18):1014-1019. doi: 10.1016/j.clinbiochem.2017.07.017. Epub 2017 Jul 29.
6
A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.一项关于口服草酸盐降解酶ALLN-177的双盲、安慰剂对照、随机1期交叉研究。
Am J Nephrol. 2016;44(2):150-8. doi: 10.1159/000448766. Epub 2016 Aug 17.
7
The management of patients with enteric hyperoxaluria.肠源性高草酸尿症患者的管理
Urolithiasis. 2016 Feb;44(1):33-43. doi: 10.1007/s00240-015-0846-5. Epub 2015 Dec 8.
8
Unexpected deterioration of graft function after combined kidney and pancreas transplantation.肾胰联合移植后移植物功能意外恶化。
Clin Kidney J. 2013 Apr;6(2):228-30. doi: 10.1093/ckj/sft012.
9
Enteric hyperoxaluria: an important cause of end-stage kidney disease.肠道高草酸尿症：终末期肾病的一个重要原因。
Nephrol Dial Transplant. 2016 Mar;31(3):375-82. doi: 10.1093/ndt/gfv005. Epub 2015 Feb 20.
10
Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts.继发性高草酸尿症：天然肾脏和肾移植中肾结石形成及肾衰竭的一个危险因素。
Transplant Rev (Orlando). 2014 Oct;28(4):182-7. doi: 10.1016/j.trre.2014.05.004. Epub 2014 May 27.